News | September 17, 2021
Skyhawk Therapeutics Completes New Investment Round
Read More
News | September 17, 2021
DICE Therapeutics Announces Pricing of Upsized Initial Public Offering
Read More
News | September 17, 2021
ImCheck Presents Preliminary Patient Response Data from the Phase I/IIa EVICTION Trial with ICT01 at ESMO Congress 2021
Read More
News | September 14, 2021
Bill Haney adds another $133M to Skyhawk’s coffers, as the RNA startup guns for the clinic
Read More
